For people with advanced AIDS-related Kaposi sarcoma in sub-Saharan Africa, results from a large clinical trial are expected to change treatment. In the trial, paclitaxel greatly improved outcomes compared with treatments typically used in the region.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2TQL6y0
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2TQL6y0